Académique Documents
Professionnel Documents
Culture Documents
Copy No :
Document # : QC-013
Prepared by
Name:Mr. Ayman Khalefa
Position: Operation Manager
(UCTD)
Signature:
Date:
Version # : 01
Compliance Approval
Name:Dr. Soad Mahmoud
Position:Quality &
Compliance Consultant
Signature:
Date:
Page # 1 of 6
1- Purpose:
Dealing with damaged & expired / going to be expired products.
Clarify stock rotation principles
2- Scope:
All warehouses in United Company For Trading and Distribution.
3- Responsibilities:
12345-
Warehouse storekeeper
Warehouse workers
Warehouse manager
Purchasing department
Warehouses Departement
4- Definitions:
first expiry/first out (FEFO)
A distribution procedure that ensures that the stock with the earliest expiry date is distributed and/or
used before the stock with a later expiry date from the same item.
Copy No :
Document # : QC-013
Prepared by
Name:Mr. Ayman Khalefa
Position: Operation Manager
(UCTD)
Signature:
Date:
Version # : 01
Compliance Approval
Name:Dr. Soad Mahmoud
Position:Quality &
Compliance Consultant
Signature:
Date:
Page # 2 of 6
2-When UCTD receives safety report where the invented name of the medicinal product is not
specified but only mention the active substance, and the active substance is included in more than one
pharmaceutical product, UCTD should assume that the report may relate to any of these
pharmaceutical products and must send reports to each of all relevant MAHs.
3-When information is received directly from a Patient/Consumer suggesting that an adverse reaction
may have occurred, UCTD should attempt to obtain the Patient's consent to inform MAH in order to
contact the Healthcare Professional involved for further information.
4- When a Consumer submits medical documentation that supports the occurrence of the adverse
reaction, this should be attached with the report.
Copy No :
Document # : QC-013
Prepared by
Name:Mr. Ayman Khalefa
Position: Operation Manager
(UCTD)
Signature:
Date:
Version # : 01
Compliance Approval
Name:Dr. Soad Mahmoud
Position:Quality &
Compliance Consultant
Signature:
Date:
Page # 3 of 6
5-When UCTD receives medical enquiry(s) from the Egyptian Health Authorities or Health Care
Professional (HCP),UCTD must translate it into English and send it to the MAH on timely manner as
per the PV agreement signed with the MAH.
The MAH should transmit all ICSRs requiring expedited reporting promptly and not later
than 15 calendar days from receipt. This applies to the initial and follow-up information,
while other reports that do not require expedited reporting should be reported to Egyptian
Pharmacovigilance Center (EPVC) within 90 days.
UCTD must inform the MAH promptly with any adversereactionreceived either from
Healthcare Professional or from patients.
7-5Recording of ADR
1-If the MAH has specific format regarding thePharmacovigilancereports,UCTD must fill in these
form(s) all the available information.
2-If the MAH has no specific forms, UCTD must send all the available information relating to the
adverse reaction itself and that relating to the source of thereaction.
Copy No :
Document # : QC-013
Prepared by
Name:Mr. Ayman Khalefa
Position: Operation Manager
(UCTD)
Signature:
Date:
Version # : 01
Compliance Approval
Name:Dr. Soad Mahmoud
Position:Quality &
Compliance Consultant
Signature:
Date:
Page # 4 of 6
8- Reference Document :
Egyptian Guideline onPharmacovigilance for Medicinal Products for Human Use -Guideline for
Marketing Authorization Holders- Version 01 /January 2012
9- Forms / Attachments:
Marketing Authorization Holders
Copy No :
Document # : QC-013
Prepared by
Name:Mr. Ayman Khalefa
Position: Operation Manager
(UCTD)
Signature:
Date:
Version # : 01
Compliance Approval
Name:Dr. Soad Mahmoud
Position:Quality &
Compliance Consultant
Signature:
Date:
Page # 5 of 6
10. History
Effective Date
Version
Change Summary
10/02/2015
01
1st issue